Related Experiment Video
Updated: May 4, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
Published on: June 22, 2020
Atypical phenotypes in titinopathies explained by second titin mutations
Anni Evilä1, Anna Vihola, Jaakko Sarparanta
1Folkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
Objective:
Several patients with previously reported titin gene (TTN) mutations causing tibial muscular dystrophy (TMD) have more complex, severe, or unusual phenotypes. This study aimed to clarify the molecular cause of the variant phenotypes in 8 patients of 7 European families.
Methods:
Clinical, histopathological, and muscle imaging data of patients and family members were reanalyzed. The titin protein was analyzed by Western blotting and TTN gene by reverse transcription polymerase chain reaction (RT-PCR) and Sanger sequencing.
Results:
Western blotting showed more pronounced C-terminal titin abnormality than expected for heterozygous probands, suggesting the existence of additional TTN mutations. RT-PCR indicated unequal mRNA expression of the TTN alleles in biopsies of 6 patients, 3 with an limb-girdle muscular dystrophy type 2J (LGMD2J) phenotype. Novel frameshift mutations were identified in 5 patients. A novel A-band titin mutation, c.92167C>T (p.P30723S), was found in 1 patient, and 1 Portuguese patient with a severe TMD phenotype proved to be homozygous for the previously reported Iberian TMD mutation.
Interpretation:
The unequal expression levels of TTN transcripts in 5 probands suggested severely reduced expression of the frameshift mutated allele, probably through nonsense-mediated decay, explaining the more severe phenotypes. The Iberian TMD mutation may cause a more severe TMD rather than LGMD2J when homozygous. The Finnish patient compound heterozygous for the FINmaj TMD mutation and the novel A-band titin missense mutation showed a phenotype completely different from previously described titinopathies. Our results further expand the complexity of muscular dystrophies caused by TTN mutations and suggest that the coexistence of second mutations may constitute a more common general mechanism explaining phenotype variability.
Insights
Complex titin gene (TTN) mutations cause varied muscular dystrophy phenotypes. This study identified novel mutations and unequal mRNA expression, revealing a common mechanism for severe disease and expanded understanding of titinopathies.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Titin gene (TTN) mutations are linked to tibial muscular dystrophy (TMD).
- Some patients exhibit complex, severe, or unusual phenotypes beyond typical TMD.
- Understanding the genetic basis of these variant phenotypes is crucial.
Purpose of the Study:
- To investigate the molecular causes of varied phenotypes in patients with TTN mutations.
- To analyze genetic and molecular data from 8 patients across 7 European families.
- To clarify the role of TTN mutations in muscular dystrophy variability.
Main Methods:
- Reanalysis of clinical, histopathological, and muscle imaging data.
- Western blotting for titin protein analysis.
- RT-PCR and Sanger sequencing for TTN gene analysis.
Main Results:
- Western blotting revealed more severe C-terminal titin abnormalities than expected.
- Unequal mRNA expression of TTN alleles was observed in 6 patients.
- Novel frameshift mutations were identified in 5 patients; one patient had a novel A-band titin mutation.
Conclusions:
- Unequal TTN transcript expression suggests reduced expression of mutated alleles, explaining severe phenotypes.
- Homozygosity for the Iberian TMD mutation may lead to severe TMD, not LGMD2J.
- Coexisting TTN mutations represent a significant mechanism for muscular dystrophy phenotype variability.
Related Concept Videos
The Sarcomere
Each...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Alterations in Muscle Tone lll
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...

